Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
The study is a randomized trial of two different screening methods for early detection of liver cancer in patients with cirrhosis of the liver. The goal of PREMIUM is to compare an abbreviated version of the diagnostic gold standard for HCC (aMRI) +AFP to the standard-of-care screening (US+AFP) in patients at high risk of developing HCC. The investigators hypothesize that HCC will be detected at earlier stages, allowing for more curative treatments and resulting in a reduction in HCC-related mortality.
Epistemonikos ID: 46dc101f774899806bc0b6431308a904dcf90770
First added on: May 13, 2024